Medicines and hospitals brazilian health system: the impact of pharmacy and therapeutics committees

Authors

  • Rafael Santos Santana
  • Geovanna Cunha Cardoso
  • Iza Maria Fraga Lobo
  • Ellen Karla Chavez Vieira Koga
  • Wellington Barros da Silva

DOI:

https://doi.org/10.30968/rbfhss.2018.092.006

Abstract

This study aimed to analyze the economic and access impact, beyond the levels of essential drug lists of public hospitals after the establishment of Pharmacy and Therapeutics (P&T) committees. As a result, there has been a decrease of total number of medicines from a level of 716 items to 516 (27.8%). There was an increase in items of Brazilian Medicines List (13.6%), WHO Model List (10.5%) and medicines indicated by clinical guidelines (14.7%). Economic analysis shows that the costs of essential medicines list decrease in approximately 12%. The results obtained demonstrated the great potential of the P&T committee contribution in optimizing resources.

Downloads

Download data is not yet available.

Published

2018-06-30

How to Cite

1.
Santana RS, Cardoso GC, Lobo IMF, Koga EKCV, Silva WB da. Medicines and hospitals brazilian health system: the impact of pharmacy and therapeutics committees. Rev Bras Farm Hosp Serv Saude [Internet]. 2018Jun.30 [cited 2024May18];9(2). Available from: https://rbfhss.org.br/sbrafh/article/view/319

Issue

Section

ORIGINAL ARTICLES

Most read articles by the same author(s)